Why Does It Matter to Know Early?

It is a reasonable question: if you cannot change your DNA, what is the point of knowing what is in it?

The concern behind the question is understandable. If a variant cannot be removed or repaired, testing might seem to deliver worry without a solution. But this framing misses the central fact: knowing about a variant does not change your DNA, but it fundamentally changes what you and your healthcare team can do about the risk it confers.

The difference between knowing and not knowing is clinical. In many cases, it is the difference between a cancer detected early and a cancer detected late.

Stage at Diagnosis Changes Everything

Cancer outcomes are heavily influenced by the stage at which disease is found:

• Breast cancer: Five-year relative survival is approximately 99 percent for localized disease and approximately 31 percent for distant-stage disease.
• Colorectal cancer: Approximately 91 percent for localized disease and approximately 15 percent for distant-stage disease.
• Ovarian cancer: Approximately 93 percent for localized disease and approximately 31 percent for distant-stage disease — and the majority of ovarian cancers in the general population are diagnosed at advanced stages.

These differences are not small. Earlier detection translates directly to less aggressive treatment, better treatment response, and higher survival.

What Knowing Makes Possible

Identifying a hereditary variant unlocks clinical tools that are not available to individuals unaware of their risk:

Earlier and more sensitive screening. Standard screening guidelines are designed for average-risk individuals. For someone with a hereditary variant, standard screening is insufficient. Enhanced protocols start earlier (breast MRI at age 25 for BRCA carriers, versus mammography at age 40 for average-risk women), use more sensitive imaging, and screen more frequently — creating more opportunities to catch cancer while it is small and localized.

Risk-reducing interventions. For some variants, medications can reduce cancer incidence by 30 to 50 percent. Preventive surgery can reduce risk by 80 to 95 percent. These options exist only for individuals who know their genetic status.

Informed family planning. A hereditary variant has implications for biological relatives. Cascade testing can extend early detection and prevention benefits across an entire family. Parents who know their status can make informed reproductive decisions, including the option of preimplantation genetic testing. Learn more about what happens after a positive result.

The Cost of Not Knowing

Without knowledge of a variant, an individual receives screening calibrated to average risk. For breast cancer, that means mammography beginning at age 40 — potentially 15 years after enhanced screening would have begun for a known BRCA carrier. For colorectal cancer, standard colonoscopy at age 45 — potentially 20 or more years after a Lynch syndrome carrier would have started surveillance.

During that gap, cancer can develop and progress undetected. When eventually found, it is more likely to be at an advanced stage with a less favorable prognosis.

Research estimates that only 6.8 to 20 percent of individuals who meet clinical criteria for hereditary cancer testing have actually been tested. The remainder are managing their health without information that could change their outcomes.

Knowing Is Not the Same as Worrying

Studies consistently find that cancer-related distress decreases over time after genetic testing — even among those who receive positive results. The period of highest anxiety is typically before results, not after. For most people, the uncertainty of not knowing is more burdensome than the clarity of an answer. A positive result replaces vague worry with a concrete plan. Learn more about managing fear and anxiety about genetic testing.

A Different Framing

A positive genetic test result in someone without cancer is an opportunity — one of the relatively few situations in medicine where risk can be identified and managed before disease occurs. Most cancers are diagnosed after symptoms appear. Hereditary cancer testing allows for a proactive approach.

The point of knowing early is not to carry a burden. It is to have options that would not otherwise exist. Find out if testing may be appropriate for you in our article on who should consider genetic testing.